Nofi Michael
Reporting owner on Forms 3, 4 and 5, CIK 1705477.
Nofi Michael reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-10.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| EWTX · Edgewise Therapeutics, Inc.CIK 1710072 | officer (Chief Financial Officer) | 1 | 2026-11-10 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| EWTX · Edgewise Therapeutics, Inc.Common Stock | 2026-11-10 | M exercised | +10,937 | $0 | 10,937 | Form 4 |
| EWTX · Edgewise Therapeutics, Inc.Common Stock | 2026-11-10 | S sold | -4,442 | $45.427 | 6,495 | Form 4 |
| EWTX · Edgewise Therapeutics, Inc.Restricted Stock Units, derivative | 2026-11-10 | M exercised | -10,937 | $0 | 32,813 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001705477-26-000003 | Edgewise Therapeutics, Inc. | 2026-11-10 |